Amanda Rosewell Shaw

1.3k total citations
24 papers, 1.0k citations indexed

About

Amanda Rosewell Shaw is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Amanda Rosewell Shaw has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 18 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Amanda Rosewell Shaw's work include Virus-based gene therapy research (20 papers), CAR-T cell therapy research (18 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Amanda Rosewell Shaw is often cited by papers focused on Virus-based gene therapy research (20 papers), CAR-T cell therapy research (18 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). Amanda Rosewell Shaw collaborates with scholars based in United States, Japan and Germany. Amanda Rosewell Shaw's co-authors include Masataka Suzuki, Malcolm K. Brenner, Norihiro Watanabe, Stephen Gottschalk, Kiyonori Tanoue, Caroline E. Porter, Andrew G. Sikora, Francesco Vetrini, Mary K. McKenna and Caroline Porter and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Amanda Rosewell Shaw

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Rosewell Shaw United States 14 761 722 473 260 123 24 1.0k
Riikka Havunen Finland 19 934 1.2× 753 1.0× 375 0.8× 335 1.3× 223 1.8× 44 1.1k
Mikko Siurala Finland 18 846 1.1× 694 1.0× 328 0.7× 300 1.2× 198 1.6× 26 986
Carlos Alberto Fajardo Spain 13 720 0.9× 475 0.7× 395 0.8× 335 1.3× 95 0.8× 16 980
Meijun Zheng China 12 501 0.7× 314 0.4× 231 0.5× 251 1.0× 78 0.6× 26 806
Siri Tähtinen Finland 20 1.0k 1.3× 837 1.2× 670 1.4× 564 2.2× 226 1.8× 32 1.6k
Suvi Sorsa Finland 13 623 0.8× 486 0.7× 239 0.5× 220 0.8× 140 1.1× 22 725
Anthony K. Park United States 11 724 1.0× 367 0.5× 214 0.5× 255 1.0× 74 0.6× 23 835
Jessica Wenthe Sweden 11 611 0.8× 312 0.4× 225 0.5× 315 1.2× 82 0.7× 24 799
Laura Evgin United States 16 639 0.8× 646 0.9× 378 0.8× 261 1.0× 121 1.0× 28 987
Sophia Z. Shalhout United States 11 366 0.5× 226 0.3× 314 0.7× 164 0.6× 75 0.6× 41 748

Countries citing papers authored by Amanda Rosewell Shaw

Since Specialization
Citations

This map shows the geographic impact of Amanda Rosewell Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Rosewell Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Rosewell Shaw more than expected).

Fields of papers citing papers by Amanda Rosewell Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Rosewell Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Rosewell Shaw. The network helps show where Amanda Rosewell Shaw may publish in the future.

Co-authorship network of co-authors of Amanda Rosewell Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Rosewell Shaw. A scholar is included among the top collaborators of Amanda Rosewell Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Rosewell Shaw. Amanda Rosewell Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biegert, Greyson, Amanda Rosewell Shaw, Daisuke Morita, et al.. (2025). Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinoma. PubMed. 33(2). 201006–201006.
2.
Shaw, Amanda Rosewell, Andrew J. Bennett, Daping Fan, & Walden Ai. (2025). Alternative splicing of KLF4 in myeloid cells: implications for cellular plasticity and trained immunity in cancer and inflammatory disease. Frontiers in Immunology. 16. 1585528–1585528.
3.
Makawita, Shalini, Caroline E. Porter, Amanda Rosewell Shaw, et al.. (2024). Binary oncolytic adenovirus in combination with HER2-specific autologous CAR VST for treatment of advanced HER2-positive solid tumors (VISTA).. Journal of Clinical Oncology. 42(16_suppl). TPS2679–TPS2679. 6 indexed citations
4.
Morita, Daisuke, Amanda Rosewell Shaw, Greyson Biegert, et al.. (2024). Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity. Journal for ImmunoTherapy of Cancer. 12(12). e009741–e009741. 1 indexed citations
5.
Shaw, Amanda Rosewell, Daisuke Morita, Caroline E. Porter, et al.. (2024). IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer. PubMed. 32(4). 200899–200899.
6.
Chen, Natalie, Daniel Wang, Caroline E. Porter, et al.. (2023). Abstract P3-06-04: Treatment of Metastatic Breast Cancer with Multipotent Oncolytic/Helper Adenovirus CAdVEC. Cancer Research. 83(5_Supplement). P3–6. 2 indexed citations
7.
Shaw, Amanda Rosewell, et al.. (2022). HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy. Cancers. 14(11). 2769–2769. 11 indexed citations
8.
Shaw, Amanda Rosewell, Caroline E. Porter, Mary K. McKenna, et al.. (2021). Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors. Communications Biology. 4(1). 368–368. 34 indexed citations
9.
Biegert, Greyson, Amanda Rosewell Shaw, & Masataka Suzuki. (2021). Current development in adenoviral vectors for cancer immunotherapy. Molecular Therapy — Oncolytics. 23. 571–581. 16 indexed citations
10.
Porter, Caroline E., Amanda Rosewell Shaw, Patricia Castro, et al.. (2020). Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors. Molecular Therapy. 28(5). 1251–1262. 114 indexed citations
11.
Watanabe, Norihiro, Mary K. McKenna, Amanda Rosewell Shaw, & Masataka Suzuki. (2020). Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment. Molecular Therapy. 29(2). 505–520. 64 indexed citations
12.
Shaw, Amanda Rosewell & Masataka Suzuki. (2019). Immunology of Adenoviral Vectors in Cancer Therapy. Molecular Therapy — Methods & Clinical Development. 15. 418–429. 59 indexed citations
13.
Shaw, Amanda Rosewell & Masataka Suzuki. (2018). Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment. Frontiers in Immunology. 9. 2103–2103. 63 indexed citations
14.
Tanoue, Kiyonori, Amanda Rosewell Shaw, Norihiro Watanabe, et al.. (2017). Armed Oncolytic Adenovirus–Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors. Cancer Research. 77(8). 2040–2051. 180 indexed citations
15.
Shaw, Amanda Rosewell, Caroline E. Porter, Norihiro Watanabe, et al.. (2017). Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer. Molecular Therapy. 25(11). 2440–2451. 178 indexed citations
16.
Shaw, Amanda Rosewell, Kiyonori Tanoue, Norihiro Watanabe, et al.. (2016). 513. Armed-Ad Gene Therapy Expressing PD-L1 Minibody Enhances the Anti-Tumor Effect of Adoptively Transferred Chimeric Antigen Receptor T-Cells for Solid Tumor Treatment. Molecular Therapy. 24. S204–S205. 1 indexed citations
17.
Shaw, Amanda Rosewell & Francesco Vetrini. (2011). Helper-Dependent Adenoviral Vectors. Journal of Genetic Syndromes & Gene Therapy. 2(2). 25 indexed citations
18.
Khare, Reeti, Shannon M. May, Francesco Vetrini, et al.. (2011). Generation of a Kupffer Cell-evading Adenovirus for Systemic and Liver-directed Gene Transfer. Molecular Therapy. 19(7). 1254–1262. 66 indexed citations
19.
Engler, Tatjana, Erika Schmidt, Francesco Vetrini, et al.. (2010). Modifications of Adenovirus Hexon Allow for Either Hepatocyte Detargeting or Targeting With Potential Evasion From Kupffer Cells. Molecular Therapy. 19(1). 83–92. 56 indexed citations
20.
Pollok, Karen E., et al.. (1993). Novel T cell antigen 4-1BB associates with the protein tyrosine kinase p56lck1.. The Journal of Immunology. 151(3). 1255–1262. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Riikka Havunen Breakdown of academic impact, for papers by Mikko Siurala Breakdown of academic impact, for papers by Carlos Alberto Fajardo Breakdown of academic impact, for papers by Meijun Zheng Breakdown of academic impact, for papers by Siri Tähtinen Breakdown of academic impact, for papers by Suvi Sorsa Breakdown of academic impact, for papers by Anthony K. Park Breakdown of academic impact, for papers by Jessica Wenthe Breakdown of academic impact, for papers by Laura Evgin Breakdown of academic impact, for papers by Sophia Z. Shalhout
Rankless by CCL
2026